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Studies of Staphylococcus aureus nasal carriage have distinguished three carriage patterns: persistent,
intermittent, and noncarriage. The criteria used to identify these carriage patterns have been inconsistent. In
1988 the S. aureus nasal carrier index, i.e., the proportion of nasal swab specimen cultures yielding S. aureus,
was determined for 91 staff members of various departments of a large university hospital by obtaining weekly
nasal swab specimens for culture over a 12-week period. Thirty-three (36%) persons had carrier indices of 0.80
or higher, 15 (17%) had indices between 0.1 and 0.7, and 43 (47%) had indices of zero. In 1995, 17 individuals
with carrier indices of 0.80 or higher in 1988 were available for reexamination. For 12 (71%) of these
individuals, S. aureus was again isolated from a single nasal swab, i.e., from each individual with a 1988 carrier
index of 1.0 but from only half of those with indices below 1.0. Genotyping (by randomly amplified polymorphic
DNA analysis and pulsed-field gel electrophoresis) of all S. aureus strains showed that strains isolated from
only three individuals, all with 1988 carrier indices of 1.0, in 1988 and 1995 showed genetic similarity. In
conclusion, persistent S. aureus nasal carriage is a unique characteristic of a fraction of the population, and
the attribute “persistent” should be confined to those individuals for whom serial nasal swab specimen cultures
consistently yield S. aureus.
Staphylococcus aureus nasal carriage has been extensively
studied in patients and healthy individuals (22, 54). Cross-
sectional surveys of S. aureus nasal carriage have designated
individuals as either carriers or noncarriers (10, 15, 17, 20, 21,
25, 29–32, 34, 35, 40, 55) (Table 1). In longitudinal studies,
however, the carrier state has been shown to change over time
in some individuals. Three carriage patterns can be distin-
guished: persistent carriage, intermittent carriage, and noncar-
riage (1, 14, 15, 19, 20, 24, 28, 30, 31, 38). However, the criteria
used to identify these carriage patterns have varied from study
to study with respect to the number of nasal specimen cultures
that are performed, the follow-up period, and the interpreta-
tion of the culture data that are obtained (Table 2). Despite
this lack of consistency, several studies have shown the impor-
tance of distinguishing persistent from intermittent nasal car-
riage. The mean number of CFU of S. aureus that can be
isolated from the anterior nares is higher in persistent carriers
than in intermittent carriers (49, 52), resulting in more exten-
sive dispersal of the staphylococci in the environment (50) and
in an increased risk of S. aureus infections (4, 5, 51). Moreover,
the number of S. aureus phage types or genotypes that are
isolated in repeated cultures is significantly lower for persistent
carriers than for intermittent carriers (15, 38, 46), indicating
that the basic determinants of persistent and intermittent car-
riage may be different.
In the present study the S. aureus nasal carrier state was
determined for 91 healthy adults during a 12-week follow-up
period. Eight years later, persistent carriers were reexamined
to investigate their current S. aureus nasal carrier state. Dif-
ferent genotyping techniques were applied to identify any ge-
netic similarity of the S. aureus strains isolated over this 8-year
period. The results provide unique evidence for the redefini-
tion of the persistent nasal carrier state.
MATERIALS AND METHODS
Study population. In 1988 a screening for S. aureus nasal carriage was per-
formed among 91 staff members of the Departments of Bacteriology, Virology,
Dermatology, Immunology, and Epidemiology of the Erasmus University Med-
ical Center, Rotterdam, The Netherlands. All 51 male and 40 female participants
were healthy adults. Nasal swab specimen cultures were performed weekly for 10
to 12 weeks. For each person the S. aureus carrier index was calculated. The
carrier index was defined as the number of nasal swab specimen cultures that
grew S. aureus divided by the total number of nasal swab specimen cultures
performed for that person. Persistent nasal carriers comprised those persons with
carrier indices of 0.80 or higher, intermittent carriers were those with carrier
indices between 0.1 and 0.70, and noncarriers were those with indices of zero. In
1995 single nasal swab specimens were obtained from 17 (52%) of the 33
persistent carriers that had been identified in 1988 and were available for re-
newed determination of their S. aureus nasal carrier state.
Nasal swabbing and isolation of S. aureus. Nasal swab specimens were ob-
tained by using sterile dry cotton-wool swabs (Transwab; Medical Wire & Equip-
ment Co. Ltd., Corsham, United Kingdom). Both the left and right anterior
nares were swabbed by rubbing the swab four times around the inside of each
nostril while applying an even pressure and rotating the swab without interrup-
tion. The swabs were immediately placed in Stuart’s transport medium (Tran-
swab; Medical Wire & Equipment Co. Ltd.) and kept at 4°C until inoculation.
In 1988 nasal swabs were inoculated within 24 h onto Columbia blood agar
plates (Becton-Dickinson B.V., Etten-Leur, The Netherlands) and phenol-red
mannitol salt agar plates (Difco-Brunschwig B.V., Amsterdam, The Nether-
lands). The plates were incubated at 37°C for 48 h. Identification of S. aureus was
based upon colony morphology, a free coagulase (tube) test (Difco-Brunschwig
B.V.), and a bound coagulase (agar) test (47) applied to suspected colonies after
demonstration of catalase positivity. For persistent carriers S. aureus isolates of
the first, sixth, and last nasal swab cultures were phage typed (National Institute
for Public Health and Environmental Hygiene, Bilthoven, The Netherlands).
One isolate per phage type was stored as a freeze-dried sample. In 1995, the
identification of all isolates obtained in 1988 was confirmed by a rapid S. aureus-
specific latex agglutination test (Staphaurex Plus; Murex Diagnostics Benelux
B.V., Utrecht, The Netherlands) (26).
In 1995 nasal swabs were inoculated within 24 h onto Columbia blood agar
plates (Becton-Dickinson B.V.) and phenol-red mannitol salt agar plates (Difco-
Brunschwig B.V.). After inoculation the swabs were placed in brain heart infu-
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sion medium, incubated at 37°C for 24 h, and subsequently inoculated onto solid
media. All solid media were incubated at 37°C for 48 h. Identification of S. aureus
was based upon colony morphology and a rapid S. aureus-specific latex aggluti-
nation test (Staphaurex Plus; Murex Diagnostics Benelux B.V.) (26), which was
applied to suspected colonies after demonstration of catalase positivity. For each
carrier up to three colonies per colony morphotype per inoculated plate were
stored in glycerol stocks at 280°C.
Genotyping. (i) RAPD. Bacteria were grown overnight on Columbia blood
agar plates (Becton-Dickinson B.V.). Two to three discrete colonies were resus-
pended in 150 ml of 25 mM Tris z HCl (pH 8.0)–10 mM EDTA–50 mM glucose.
Lysostaphin (75 ml of a 100-mg/ml solution; Sigma Chemical Co., St. Louis, Mo.)
was added, and the mixture was incubated at 37°C for 1 h. DNA isolation was
performed by the method of Boom et al. (3). Stock solutions of DNA were
adjusted to a concentration of 0.5 ng/ml and were stored at 220°C until use. PCR
and subsequent electrophoresis of the amplification products was performed
essentially as described previously (45). The primers used to discriminate S.
aureus strains were RAPD1 (59-GGTTGGGTGAGAATTGCACG-39),
RAPD7(59-GTGGATGCGA-39), and ERIC2 (59-AAGTAAGTGACTGGGGT
GAGCG-39) (45, 48). Randomly amplified polymorphic DNA (RAPD) banding
patterns were interpreted visually by two independent observers and were in-
dexed with Roman numerals. Differences in band staining intensities and single
band differences were neglected. In this way all S. aureus isolates were identified
by a three-letter code.
(ii) PFGE. Pulsed-field gel electrophoresis (PFGE) was carried out on the
basis of protocols previously described for S. aureus (6, 36). The bacteria were
grown overnight on Columbia blood agar plates (Becton-Dickinson B.V.). Two
to three discrete colonies were suspended in a 1:1 ratio in 1% InCert agarose
(FMC Bioproducts, Rockland, Maine). Agarose plugs were prepared with Bio-
Rad casting forms (Bio-Rad Inc., Veenendaal, The Netherlands) and were in-
cubated with lysostaphin (Sigma Chemical Co.). Spheroplasts were lysed by
incubating the plugs in buffer containing 1% sodium dodecyl sulfate and 1 mg of
proteinase K (Boehringer Mannheim, Mannheim, Germany) per ml. The plugs
were washed six times for 30 min each time in 10 mM Tris z HCl (pH 8.0)–1 mM
EDTA and were stored at 4°C. DNA was digested with the restriction enzyme
SmaI (Boehringer Mannheim), and PFGE was carried out in 1% SeaKem GTG
agarose gels (FMC Bioproducts) in a 0.53 TBE (Tris-borate-EDTA) buffer at a
temperature of 14°C. Electrophoresis was performed in a Bio-Rad CHEF Map-
per. The running time was 22 h, with linear ramping from 2.16 to 44.69 s at an
angle of 120°C (60°C and 260°C), at a voltage of 6 V/cm. Banding patterns were
interpreted by two independent observers according to the guidelines provided
by Tenover et al. (44). Types were defined on the basis of the identity or
nonidentity of the banding patterns and were indexed with Roman numerals.
(iii) Protein A gene PCR. Protein A gene polymorphisms were determined by
PCR as described previously (12). The repetitive X region within the spa gene
was amplified with oligonucleotide primers with the following DNA sequences:
59-TGTAAAACGACGGCCAGTGCTAAAAAGCTAAACGATGC-39 and 59-
CAGGAAACAGCTATGACCCCACCAAATACAGTTGTACC-39. The PCR
product was digested with the restriction endonuclease RsaI (Boehringer Mann-
heim), resulting in two fragments composed of 214 and 35 bases, respectively,
and a third fragment containing the variable-length repetitive DNA. The restric-
tion fragment length polymorphisms (RFLPs) of this third fragment were deter-
mined by electrophoresis. RFLP patterns were visually interpreted by two inde-
pendent observers. The number of 24-bp repeats present was determined in
comparison with a 100-bp molecular length marker (Pharmacia, Gouda, The
Netherlands).
(iv) Coagulase gene PCR. Coagulase gene polymorphism was determined by
PCR as described previously (42). The primers used for amplification of the
coagulase gene were COAG2 (59-CGAGACCAAGATTCAACAAG-39) and
COAG3 (59-AAAGAAAACCACTCACATCA-39) (13). The PCR product (10
ml) was digested with the restriction endonuclease AluI (Boehringer Mannheim).
RFLP patterns were visually interpreted by two independent observers and were
indexed with Roman numerals.
Statistical analysis. Differences in the distributions of continuous and cate-
gorical variables between groups were tested by one-way analysis of variance and
the chi-square test, respectively.
RESULTS
The carrier indices for the 91 persons screened in 1988 are
presented in Fig. 1. According to our 1988 definitions for the
nasal carrier state (see Materials and Methods), 43 (47%)
noncarriers, 15 (17%) intermittent carriers, and 33 (36%) per-
sistent carriers were identified. Population characteristics are
shown in Table 3. Sex, age, and department of employment
were not statistically significantly different for the three carrier
states.
Seventeen (52%) of the 33 persistent carriers in the 1988
screening were available for nasal swab specimen culture in
1995. The distributions of sex, age, and department of employ-
ment in 1988 for individuals available for reexamination were
comparable to those for individuals not available for reexam-
ination (data not shown). In 12 (71%) of these 1988 carriers, S.
aureus was again isolated from a single nasal swab specimen. S.
aureus isolation in 1995 was significantly more frequent in
carriers with 1988 carrier indices of 1.0 (100%) than in carriers
with 1988 indices below 1.0 (50%) (P 5 0.04). The isolation
rate for the latter group was significantly lower than the ex-
pected isolation rate of 85% (95% confidence interval, 78 to
92%) on the basis of the previous carrier indices.
All S. aureus strains isolated in 1988 and 1995 were geno-
typed by RAPD analysis and PFGE and were screened for
polymorphisms in the protein A and coagulase genes (Table 4;
Fig. 2 to 5). The results of the two whole-genome typing meth-
ods, RAPD analysis and PFGE, were quite concordant, with
the methods detecting 15 and 16 different genotypes, respec-
tively. RAPD analysis and PFGE revealed the genetic similar-
ity of the 1988 and 1995 S. aureus isolates in four and three
individuals, respectively. PFGE types G and K, isolated from
TABLE 1. S. aureus nasal carriage rates in healthy adults reported in cross-sectional surveys
Referencea Study population No. of subjects Reported carriage rate (%)
Hallman, 1937 (17) College students (United States) 109 37
Miles et al., 1944 (30) Hospital personnel (United Kingdom) 74 64
Findlay and Abrahams, 1946 (10) European medical personnel (West Africa) 100 38
African soldiers and villagers (West Africa) 300 23
Gould and McKillop, 1954 (15) Blood donors (Scotland) 86 52
Medical students (Scotland) 520 19
Rountree, 1956 (40) Unselected population (New Guinea) 120 19
Millian et al., 1960 (32) Caucasian job applicants (United States) 418 37
Negroid job applicants (United States) 139 14
Jacobs et al., 1961 (21) Nurses (United Kingdom) 178 38
Miller et al., 1962 (31) Army recruits (United Kingdom) 2,376 45
Leedom et al. 1965 (25) Hospital personnel (United States) 951 23
Noble et al., 1967 (34) Unselected population (The Netherlands) 839 30
Wilson et al., 1977 (55) Medical students (United States) 414 25
Paul et al., 1982 (35) Hospital personnel (Nigeria) 66 56
McAnally et al., 1984 (29) Hospital personnel (United States) 664 25
Hu et al., 1995 (20) Medical students (Japan) 51 22
a Author, year of publication (reference number).
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carrier 11 in 1995, and types A and N, isolated from carrier 13
in 1995, differed by two and three bands, respectively. Accord-
ing to the guidelines provided by Tenover et al. (44), these
isolates should be considered closely related, indicating that
the genomes of persistent S. aureus strains may slowly evolve in
an individual over time. The numbers of protein A repeat units
in the 1988 and 1995 isolates were identical in six carriers, but
identical numbers of protein A repeat units were detected in
isolates from only two of the three individuals for whom the
genetic similarity of the S. aureus isolates was identified by
RAPD analysis and PFGE, indicating variability within the
protein A gene of S. aureus strains that otherwise showed
constant overall genotypic characteristics. The RFLP patterns
of the coagulase genes of the 1988 and 1995 isolates were
identical in all three individuals in which the genetic similarity
of the S. aureus isolates was identified by RAPD analysis and
PFGE. In one additional carrier (carrier 15) the coagulase
gene typing patterns of the 1988 and 1995 isolates were iden-
tical, but this result could not be confirmed by RAPD analysis
or PFGE. This observation can be explained by the limited
resolution of coagulase gene typing, which is illustrated by the
data in Table 4. Only 7 coagulase gene RFLP patterns were
observed; this is in contrast to the 16 different genotypes that
were detected by PFGE. When RAPD analysis and PFGE, the
typing techniques with the highest discriminatory powers, were
combined, three carriers of S. aureus isolates with genetic sim-
ilarity in 1988 and 1995 were identified. Genetic similarity was
seen only for isolates from carriers with carrier indices of 1.0 in
the original screening in 1988. Renewed isolation of S. aureus
strains in 1995 did not seem to be associated with the number
of protein A repeats or with the coagulase gene RFLP pattern,
as the patterns observed for these strains were also found for
strains that were isolated only in 1988 (Table 4).
DISCUSSION
In the initial 12-week screening of 91 healthy adults we
identified 33 (36%) persons with S. aureus carrier indices of
0.80 or higher, 15 (17%) with carrier indices between 0.1 and
0.7, and 43 (47%) with carrier indices of zero. Eight years later,
reexamination of carriers with indices of 0.8 or higher demon-
strated that S. aureus was still present in the nares of each
individual with a carrier index of 1.0 during the initial 12-week
screening but in only half of those with 1988 indices below 1.0.
Moreover, only the 1988 and 1995 S. aureus isolates observed
FIG. 1. Distribution of S. aureus nasal carrier indices among 91 healthy
adults repeatedly cultured over a 10- to 12-week period in 1988. The carrier index
is defined as the proportion of cultures yielding S. aureus for a given individual.
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in carriers with indices of 1.0 were found to be genetically
similar.
The anterior nares have proven to be the primary reservoir
of S. aureus in humans (7, 33, 53), and S. aureus nasal carriage
has been established as a major risk factor for the development
of both community-acquired and nosocomial infections (8, 9,
23, 27). S. aureus nasal carriage has been extensively studied in
patients and healthy individuals (22, 54). Cross-sectional sur-
veys of healthy adult populations have reported S. aureus nasal
carriage rates between 20 and 55% (10, 15, 17, 20, 21, 25,
29–32, 34, 35, 40, 55). Longitudinal studies, however, indicated
that carriage patterns differ between individuals, and that 10 to
35% of individuals carry S. aureus persistently, 20 to 75% carry
S. aureus intermittently, and 5 to 70% are persistently free of S.
aureus (noncarriers) (1, 14, 15, 19, 20, 24, 28, 30, 31, 38). The
variation in reported rates results, at least partly, from differ-
ences in study populations, sampling and culture techniques,
and criteria for the definition of persistent or intermittent
carriage. First, many studies of S. aureus nasal carriage rates in
healthy adults have been performed in selected populations,
including medical students, hospital personnel, job applicants,
and blood donors (Tables 1 and 2); the reported rates may
therefore differ from those for unselected populations (34).
Second, differences in the procedures of nasal swabbing and
isolation of S. aureus may account for some variation in car-
riage rates. It has been documented that swabs from the an-
terior nares (i.e., the vestibulum nasi) yield higher carriage
rates than swabs taken from sites beyond this region (21, 33).
A recent study has shown that the number of carriers in a given
population is also dependent on the swab material, the trans-
port medium, the medium for cultivation, and the incubation
period (37). However, this was not true for the identification of
persistent carriers, which was confirmed by our finding that
broth enrichment of the 1995 nasal swabs did not result in the
FIG. 2. RAPD analysis with primer ERIC2 of S. aureus strains isolated in
1988 and 1995 from carriers 2, 11, 12, and 14. The arrows on the left and right
identify the molecular length marker that is 600 bp long in the 100-bp ladder. The
other fragments differ in size by multiples of 100 bp in length. Neg., negative
control.
FIG. 3. PFGE of S. aureus strains isolated in 1988 and 1995 from carriers 2,
11, 12, and 14. The lane marked lambda contains bacteriophage lambda con-
catemers that differ in size by multiples of 50 kbp.
TABLE 3. Distribution of sex, age, and department of employment by S. aureus nasal carrier state among 91 healthy adults repeatedly
sampled for culture over a 10- to 12-week period in 1988
Characteristic
S. aureus nasal carrier statea
P
Noncarriage (n 5 43) Intermittent carriage (n 5 15) Persistent carriage (n 5 33) Overall (n 5 91)
Male/female ratio 0.6 0.7 1.2 0.8 0.30b
Age (yr) (mean [SD]) 30.3 (9.5) 28.2 (7.2) 33.4 (8.2) 31.0 (8.8) 0.13c
Department (no. [%] of subjects)
Bacteriology 7 (16) 5 (33) 13 (40) 25 (27) 0.60d
Virology 4 (9) 1 (7) 2 (6) 7 (8)
Dermatology 6 (14) 1 (7) 2 (6) 9 (10)
Immunology 18 (42) 6 (40) 10 (30) 34 (37)
Epidemiology 8 (19) 2 (13) 6 (18) 16 (18)
a The nasal carrier state was defined according to the carrier index (i.e., the proportion of cultures yielding S. aureus for a given individual). Noncarriage, carrier index
of 0; intermittent carriage, carrier indices of 0.1 to 0.7; persistent carriage, carrier indices of 0.8 to 1.0.
b x2 5 2.392 (2 degrees of freedom).
c F 5 2.096 (degrees of freedom, between and within, 2 and 88, respectively).
d x2 5 6.387 (8 degrees of freedom).
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TABLE 4. Genotyping of S. aureus strains isolated in nasal carriers in 1988 and 1995
Carrier no. Carrier indexa Yr of culture Isolation of S. aureus
Genotyping
RAPD PFGE No. of protein A repeatsb Coagulase gene
1 0.80 1988 Yes NDc ND ND ND
1995 No
2 0.83 1988 Yes AAA A 3 A
1995 Yes BBB B 9 B
CBB C 13 C
3 0.83 1988 Yes ND ND ND ND
1995 No
4 0.83 1988 Yes DCC D 10d D
1995 Yes EAA E 3 A
BBD B 10d B
5 0.83 1988 Yes BBB B 10d B
1995 Yes BBD F 11 E
BBD G 11 E
BBD F 10d E
6 0.83 1988 Yes FDEd H 12 F
1995 Yes FDEd I 7 B
7 0.83 1988 Yes ND ND ND ND
1995 No
8 0.92 1988 Yes ND ND ND ND
1995 No
9 0.92 1988 Yes AAA J 1 A
1995 Yes FDF G 11 E
10 0.92 1988 Yes ND ND ND ND
1995 No
11 1.00 1988 Yes AAA A 9 A
1995 Yes GDE Ge 13 E
GDE Ke 13 E
12 1.00 1988 Yes HCCd Ld 9 Ed
1995 Yes HCCd Ld 5 Ed
ICC M 5 Ed
13 1.00 1988 Yes AEAd Ad 7d Ad
1995 Yes AEAd Ad,f 7d Ad
AEAd Nf 7d Ad
14 1.00 1988 Yes DCCd Od 9d Gd
1995 Yes DCCd Od 9d Gd
15 1.00 1988 Yes HCC D 10d Ed
1995 Yes JBB B 10d Ed
16 1.00 1988 Yes GCG C 10 E
1995 Yes FBE P 9 F
17 1.00 1988 Yes FDF G 8d H
1995 Yes BBB B 8d B
Total no. of genotypes 15 14 10 8
a The carrier index is defined as the proportion of nasal cultures yielding S. aureus for a given individual.
b The number of protein A repeats as assessed by RFLP analysis.
c ND, not done.
d Long-term persistence of molecular type.
e Closely related genotypes; only a two-band difference.
f Closely related genotypes; only a three-band difference.
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detection of additional carriers. Thus, noncarriage in some
individuals was not due to the presence of only small numbers
of bacteria in the anterior nares. Third, and perhaps most
important, differences in reported carriage rates are also due
to the various definitions used to assign the persistent and
intermittent carrier state. The criteria used to assign an indi-
vidual to either carriage pattern have varied from study to
study in terms of both the interval and the number of cultures
performed and the required proportion of cultures that grow S.
aureus (Table 2). Persistent carriage rates as well as noncar-
riage rates tend to decrease with increasing follow-up periods
and decreasing culture intervals, indicating that intermittent
carriers may be misclassified as either persistent carriers or
noncarriers if the follow-up period is short or when only a few
specimens are cultured. Obviously, persistent carriage rates
decrease if the required proportion of cultures that grow S.
aureus, i.e., the carrier index, increases. In the present fol-
low-up of S. aureus carriers with 1988 carrier indices of $0.8,
the observed S. aureus carriage rate in 1995 was significantly
lower than that expected for individuals with initial carrier
indices of 0.8 or 0.9. In carriers with 1988 indices of 1.0,
however, S. aureus was again isolated from all individuals,
suggesting that the starting point in the identification of per-
sistent S. aureus nasal carriage during a relatively short fol-
low-up period should be the isolation of S. aureus in 100% of
the nasal swab specimen cultures. The correct separation of
the population into persons who are true persistent carriers
versus those who carry S. aureus only intermittently may be
highly relevant, since it allows studies into the molecular and
genetic basis of S. aureus nasal carriage to become better
focused. Moreover, it may have a direct clinical impact when
one is designing intervention strategies because of the risks of
infection associated with S. aureus nasal carriage. As the risks
of S. aureus nasal carriage differ for intermittent and persistent
carriers, the distinction between intermittent and persistent
carriage enables the differential application of elimination
strategies, which reduces costs and diminishes the risk of the
development of antibiotic resistance. To our knowledge no
data on the long-term persistence of S. aureus nasal carriage in
healthy persons are available. Follow-up periods in longitudi-
nal studies of S. aureus nasal carriage in healthy individuals
have varied from 6 weeks to 5 years (1, 14, 15, 19, 20, 24, 28, 31,
38) (Table 2). In the present study, 71% of persistent S. aureus
nasal carriers, as defined in the initial 12-week screening in
1988, were again identified as nasal carriers 8 years later. The
finding of genetic similarity of strains isolated over such a long
time frame in one-third of these carriers suggests that nasal
carriage may persist for years, although intermittent coloniza-
tion with these S. aureus strains over the 8-year period cannot
be excluded. The persistence of single S. aureus clones in some
of the carriers confirms previous reports on the exchange of S.
aureus strains over time in nasal carriers (15, 28, 38, 46). A
recent study noted that the S. aureus exchange rate was signif-
icantly higher in intermittent carriers than in persistent carriers
(46), which would agree with our finding that the persistence of
single S. aureus clones occurred only in carriers with carrier
indices of 1.0.
Many different typing methods have been used to study
clonal relatedness between S. aureus strains (43). PFGE and
RAPD analysis are considered to be among the most reliable
and reproducible whole-genome typing procedures (43, 45),
with even increased resolution when combined analyses are
performed (45). RFLP analyses of the genes encoding S. au-
reus proteins, such as protein A and coagulase, have also been
applied as genotyping techniques (11–13, 18, 41–43). Although
it has been suggested that protein A genotyping may be an
important tool in the clonal analysis of methicillin-resistant S.
aureus isolates (11), our data confirm the findings of recent
studies that reported striking heterogeneity in the number of
protein A gene repeat units in otherwise genetically highly
related S. aureus isolates (18, 46), indicating that the protein A
gene behaves in a hypervariable, unstable manner that is un-
related to the overall evolution of the S. aureus genome. Co-
agulase gene typing has been successful in the identification of
outbreak-related strains (13, 18, 42, 43); however, unrelated
strains may share identical AluI RFLP patterns (41, 43), sug-
gesting that it should not be used as the sole method for the
typing of S. aureus. In this study only 7 coagulase genotypes
were observed, whereas 15 were observed by RAPD analysis
and 16 were observed by PFGE, confirming the lower discrim-
inatory power of coagulase gene typing compared to those of
RAPD analysis and PFGE.
Protein A and coagulase, S. aureus proteins that protrude
from the bacterial surface, have been suggested to play a role
in the process of adherence of S. aureus to host cell structures
(2, 16) and the epidemic behavior of S. aureus (12, 39). As
FIG. 4. Protein A gene PCR of S. aureus strains isolated in 1988 and 1995
from carriers 2, 11, 12, and 14. The arrows on the left and right identify the
molecular length marker that is 600 bp long in the 100-bp ladder. The other
fragments differ by multiples of 100 bp in length.
FIG. 5. Coagulase gene PCR of S. aureus strains isolated in 1988 and 1995
from carriers 2, 11, 12, and 14. The arrows on the left and right identify the
molecular length marker that is 600 bp in the 100-bp ladder. The other fragments
differ by multiples of 100 bp in length. Neg., negative control.
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polymorphisms in the genes that encode these proteins might
be related to the efficiency of S. aureus adherence, we studied
whether there was a relation between the composition of the
coagulase genes and/or protein A genes of S. aureus strains and
the likelihood of isolation of these specific strains after 8 years.
Confirming recent data (46), the results of this study do not
provide evidence of such a relation.
In summary, the lack of consistency in defining the S. aureus
nasal carrier states has resulted in striking variations in re-
ported carriage rates. Major factors that should be considered
when comparing carriage rates are the population studied, the
sampling and culture techniques applied, the follow-up period,
the number of cultures available, and the criteria used to dis-
tinguish intermittent from persistent carriers. The results of
this study indicate that persistent carriage of S. aureus is a
unique characteristic of a fraction of the population and that
the attribute “persistent” should be confined to those individ-
uals for whom serial nasal swab specimen cultures uniformly
and consistently yield S. aureus.
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